Deferoxamine
- Product NDC
- 63323-599
- 11-digit product format
- 633230599
- Labeler code
- 63323
- Product ID
- 63323-599_6e384a23-a8c4-455a-b84b-847393d491e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DEFEROXAMINE MESYLATE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA078718
- Marketing category
- ANDA
- Marketing start
- 2009-12-15
- Substance
- DEFEROXAMINE MESYLATE
- Active strength
- 95 mg/mL
- Pharmacologic classes
- Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Deferoxamine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEFEROXAMINE MESYLATE | 95 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V9TKO7EO6K |
| Rxcui | 1731345, 1731350 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-599-30 | Deferoxamine | 21.1 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 21.1 | | 8 |
| 63323-599-30 | Deferoxamine | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DEFEROXAMINE MESYLATE | ACTIVE INGREDIENT | V9TKO7EO6K | DEFEROXAMINE (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 4 | |
| DEFEROXAMINE | ACTIVE MOIETY | J06Y7MXW4D | DEFEROXAMINE (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-599 | DEFEROXAMINE (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 8 | Current NDC, Legacy NDC, 2 package rows | 20250330_d91e16df-8daa-4cd2-86a2-273eaa2446e0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-599-30 | 63323059930 | 1 VIAL in 1 BOX (63323-599-30) / 21.1 mL in 1 VIAL | 1 vial | 2009-12-15 | 0000-00-00 | No | No | Current |